| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Revenue | $634.6M | -2.7% |
| Cost of Revenue | $316.9M | -1.6% |
| Gross Profit | $317.7M | -3.8% |
| R&D Expense | $101.4M | +3.5% |
| SG&A Expense | $108.0M | +22.7% |
| Operating Income | -$1.19B | -26.4% |
| Interest Expense | $102.5M | +33.4% |
| Pre-tax Income | -$1.27B | -30.6% |
| Income Tax | -$82.4M | +67.1% |
| Net Income | -$1.07B | -64.9% |
| EPS (Basic) | -$3.52 | -63.7% |
| EPS (Diluted) | -$3.52 | -63.7% |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $134.5M | +44.6% |
| Accounts Receivable | $161.6M | -7.6% |
| Current Assets | $339.4M | +11.5% |
| Total Assets | $3.14B | -28.6% |
| Current Liabilities | $339.0M | +0.8% |
| Long-term Debt | $1.05B | -0.6% |
| Total Liabilities | $1.56B | -7.0% |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $84.9M | +24.6% |
| Capital Expenditures | $29.3M | -39.1% |
| Investing Cash Flow | -$29.3M | +87.2% |
| Financing Cash Flow | -$14.0M | -115.5% |
| Free Cash Flow | $55.6M | +177.6% |
| Stockholders' Equity |
| $1.48B |
| -40.7% |